Terms: = Liver cancer AND CRTC1, Q6UUV9, 23373, ENSG00000105662, KIAA0616, TORC1, MECT1, WAMTP1, FLJ14027
7 results:
1. Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma.
Hou P; Su X; Cao W; Xu L; Zhang R; Huang Z; Wang J; Li L; Wu L; Liao W
Diagn Pathol; 2021 Apr; 16(1):29. PubMed ID: 33832503
[TBL] [Abstract] [Full Text] [Related]
2. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
Zhang Y; Yan Q; Gong L; Xu H; Liu B; Fang X; Yu D; Li L; Wei T; Wang Y; Wong CN; Lyu Z; Tang Y; Sham PC; Guan XY
Oncogene; 2021 Feb; 40(6):1147-1161. PubMed ID: 33323975
[TBL] [Abstract] [Full Text] [Related]
3. The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis.
Wang X; Rusin A; Walkey CJ; Lin JJ; Johnson DL
J Biol Chem; 2019 Dec; 294(50):19255-19268. PubMed ID: 31645432
[TBL] [Abstract] [Full Text] [Related]
4. mTOR Inhibitors in Advanced Biliary Tract cancers.
Wu CE; Chen MH; Yeh CN
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30682771
[TBL] [Abstract] [Full Text] [Related]
5. Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.
Shi Y; Daniels-Wells TR; Frost P; Lee J; Finn RS; Bardeleben C; Penichet ML; Jung ME; Gera J; Lichtenstein A
Cancer Res; 2016 Oct; 76(19):5822-5831. PubMed ID: 27530328
[TBL] [Abstract] [Full Text] [Related]
6. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/torc1/ZEB1 pathways in colon cancer.
Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
[TBL] [Abstract] [Full Text] [Related]
7. Preclinical trial of a new dual mTOR inhibitor, MLN0128, using renal cell carcinoma tumorgrafts.
Ingels A; Zhao H; Thong AE; Saar M; Valta MP; Nolley R; Santos J; Peehl DM
Int J Cancer; 2014 May; 134(10):2322-9. PubMed ID: 24243565
[TBL] [Abstract] [Full Text] [Related]